1.Guidelines of Treatment for Bleeding Peptic Ulcer Disease.
Il Kwun CHUNG ; Dong Ho LEE ; Heung Up KIM ; In Kyung SUNG ; Jin Ho KIM
The Korean Journal of Gastroenterology 2009;54(5):298-308
Peptic ulcer (PU) bleeding is the main cause of non-variceal gastrointestinal bleeding. Negative outcomes include re-bleeding and death, and many of the deaths are associated with decompensation of coexisting medical conditions precipitated by acute bleeding event. Accurate analysis of risk for clinical features can help physician to decide treatment modality. Endoscopy can detect bleeding stigmata and perform therapeutic hemostasis. Proton pump inhibitor (PPI) compared with placebo or H2RA reduces mortality following PU bleeding among patients with high-risk endoscopic findings, and reduces re-bleeding rates and surgical intervention. PPI treatment initiated prior to endoscopy in upper gastrointestinal (UGI) bleeding significantly reduces the proportion of patients with stigmata of recent hemorrhage (SRH) at index endoscopy but does not reduce mortality, re-bleeding or the need for surgery. The strategy of giving oral PPI before and after endoscopy, with endoscopic hemostasis for those with major SRH, is likely to be the most cost-effective. The treatment of H. pyori infection was found to be more effective than anti-secretory therapy in preventing recurrent bleeding from PU. H. pyori eradication alone and eradication followed by misoprostol (with switch to PPI, if misoprostol is not tolerated) are the two most cost-effective strategies to prevent ulcer bleeding among H. pyori-infected NSAID users, although the data cannot exclude PPIs also being cost-effective treatment. This review focuses specifically on the current treatment of patients with acute bleeding from a peptic ulcer.
Anti-Ulcer Agents/therapeutic use
;
Endoscopy, Gastrointestinal
;
Gastrointestinal Hemorrhage/diagnosis
;
Helicobacter Infections/diagnosis/drug therapy
;
Helicobacter pylori
;
Hemostasis, Endoscopic
;
Humans
;
Misoprostol/therapeutic use
;
Peptic Ulcer/surgery/*therapy
;
Peptic Ulcer Hemorrhage/surgery/*therapy
;
Proton Pump Inhibitors/therapeutic use
2.Comparison of Clinical Characteristics and Outcomes between Geriatric and Non-geriatric Patients in Peptic Ulcer Bleeding.
Youn Ju NA ; Ki Nam SHIM ; Min Jung KANG ; Ji Min JUNG ; Seong Eun KIM ; Sung Ae JUNG ; Kwon YOO ; Il Hwan MOON
The Korean Journal of Gastroenterology 2009;53(5):297-304
BACKGROUND/AIMS: In geriatric patients with peptic ulcer, the use of NSAID and prevalence of chronic illness have been increased, but the Helicobacter pylori (H. pylori) infected portion decreased. The aim of this study was to evaluate the clinical characteristics and outcomes of geriatric patients (aged 65 or older) with peptic ulcer bleeding and compare with non-geriatric patients (less than 65 years old). METHODS: We conducted a retrospective study of 88 patients with peptic ulcer bleeding treated with therapeutic endoscopy from January 2006 to December 2006. We compared the clinical characteristics and outcomes of geriatric patients (n=34, 38.6%) with those of non-geriatric patients (n=54, 61.4%). RESULTS: Hypertension (52.9% vs. 24.1%), cardiovascular disease (35.3% vs. 13.0%), and chronic obstructive pulmonary disease (20.6% vs. 3.7%) were more prevalent in the geriatric group, compared with the non-geriatric group (p<0.05). The geriatric group had taken more ulcerogenic drugs than the non-geriatric group (64.7% vs. 33.3%, p<0.05); aspirin plus clopidogrel (23.6% vs. 13.0%) and aspirin (20.6% vs. 11.0%). Sixteen (21.1%) of the 76 cases had H. pylori-negative ulcer. Between the two groups, there was no difference in the prevalence of H. pylori-negative ulcer (25.9% vs. 18.4%, p>0.05). The amount of transfusion length of ICU stay, rebleeding rate, operation rate and mortality were not different between the two groups. The length of hospital stay in the geriatric patients was significantly longer than the non-geriatric group (12.3+/-10.6 vs. 7.2+/-5.9 days, p<0.05). In multiple regression analysis, old age was a significant risk factor for longer hospital stay (p<0.05). CONCLUSIONS: The geriatric patients with bleeding peptic ulcer had longer hospital stay than the non-geriatric patients in our study. The important emerging etiologies such as ulcerogenic drug and associated chronic illness should be checked and treated in these patients.
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Duodenal Ulcer/*diagnosis/surgery/therapy
;
Female
;
Humans
;
Length of Stay
;
Male
;
Medication Adherence
;
Middle Aged
;
Peptic Ulcer Hemorrhage/*diagnosis/surgery/therapy
;
Retrospective Studies
;
Stomach Ulcer/*diagnosis/surgery/therapy
;
Treatment Outcome
3.A Case of Intramural Duodenal Hematoma Accompanied by Acute Pancreatitis Following Endoscopic Hemostasis for Duodenal Ulcer Bleeding.
Min Keun SONG ; Joon Beom SHIN ; Ha Na PARK ; Eun Jin KIM ; Ki Cheun JEONG ; Dong Hwan KIM ; Jae Bock CHUNG ; Do Young KIM
The Korean Journal of Gastroenterology 2009;53(5):311-314
Intramural duodenal hematoma is an uncommon condition, which usually develops after blunt abdominal trauma. It is also reported as a complication of anticoagulant therapy, blood dyscrasia, pancreatic disease, and diagnostic and therapeutic endoscopy. The typical clinical pictures of intramural duodenal hematoma consist of upper abdominal pain, vomiting, fever, and hematochezia, and it is rarely accompanied by intestinal obstruction, peritonitis, and pancreatitis as its complication. We report a case of intramural duodenal hematoma extended to peritoneal cavity, and accompanied by acute pancreatitis following therapeutic endoscopy for duodenal ulcer bleeding in a 32-year-old man who was on maintenance of anti-coagulation therapy after valvular heart surgery.
Acute Disease
;
Adult
;
Diagnosis, Differential
;
Duodenal Diseases/*diagnosis/pathology/surgery
;
Duodenal Ulcer/*complications
;
Hematoma/*diagnosis/pathology/surgery
;
*Hemostasis, Endoscopic
;
Humans
;
Male
;
Pancreatitis/complications/*diagnosis
;
Peptic Ulcer Hemorrhage/*therapy
;
Postoperative Complications
;
Tomography, X-Ray Computed
4.Prevention, diagnosis and treatment of perioperative complications of bariatric and metabolic surgery.
Haifu WU ; Ming ZHONG ; Di ZHOU ; Chenye SHI ; Heng JIAO ; Wei WU ; Xinxia CHANG ; Jing CANG ; Hua BIAN
Chinese Journal of Gastrointestinal Surgery 2017;20(4):393-397
Surgical operation in treating obesity and type 2 diabetes is popularizing rapidly in China. Correct prevention and recognition of perioperation-related operative complications is the premise of ensuring surgical safety. Familiar complications of the operation include deep venous thrombosis, pulmonary artery embolism, anastomotic bleeding, anastomotic fistula and marginal ulcer. The prevention of deep venous thrombosis is better than treatment. The concrete measures contain physical prophylaxis (graduated compression stocking and intermittent pneumatic compression leg sleeves) and drug prophylaxis (unfractionated heparin and low molecular heparin), and the treatment is mainly thrombolysis or operative thrombectomy. The treatment of pulmonary artery embolism includes remittance of pulmonary arterial hypertension, anticoagulation, thrombolysis, operative thrombectomy, interventional therapy and extracorporeal membrane oxygenation (ECMO). Hemorrhage is a rarely occurred but relatively serious complication after bariatric surgery. The primary cause of anastomotic bleeding after laparoscopic gastric bypass is incomplete hemostasis or weak laparoscopic repair. The common bleeding site in laparoscopic sleeve gastrectomy is gastric stump and close to partes pylorica, and the bleeding may be induced by malformation and weak repair technique. Patients with hemodynamic instability caused by active bleeding or excessive bleeding should timely received surgical treatment. Anastomotic fistula in gastric bypass can be divided into gastrointestinal anastomotic fistula and jejunum-jejunum anastomotic fistula. The treatment of postoperative anastomotic fistula should vary with each individual, and conservative treatment or operative treatment should be adopted. Anastomotic stenosis is mainly related to the operative techniques. Stenosis after sleeve gastrectomy often occurs in gastric angle, and the treatment methods include balloon dilatation and stent implantation, and surgical treatment should be performed when necessary. Marginal ulcer after gastric bypass is a kind of peptic ulcer occurring close to small intestine mucosa in the junction point of stomach and jejunum. Ulcer will also occur in the vestige stomach after laparoscopic sleeve gastrectomy, and the occurrence site locates mostly in the gastric antrum incisal margin. Preoperative anti-HP (helicobacter pylorus) therapy and postoperative continuous administration of proton pump inhibitor (PPI) for six months is the main means to prevent and treat marginal ulcer. For patients on whom conservative treatment is invalid, endoscopic repair or surgical repair should be considered. Different surgical procedures will generate different related operative complications. Fully understanding and effectively dealing with the complications of various surgical procedures through multidisciplinary cooperation is a guarantee for successful operation.
Anastomosis, Surgical
;
adverse effects
;
Anticoagulants
;
therapeutic use
;
Bariatric Surgery
;
adverse effects
;
Catheterization
;
China
;
Conservative Treatment
;
Constriction, Pathologic
;
etiology
;
therapy
;
Digestive System Fistula
;
etiology
;
therapy
;
Endoscopy, Gastrointestinal
;
methods
;
Extracorporeal Membrane Oxygenation
;
Gastrectomy
;
adverse effects
;
Gastric Bypass
;
adverse effects
;
Gastric Mucosa
;
pathology
;
Gastric Stump
;
physiopathology
;
surgery
;
Gastrointestinal Hemorrhage
;
etiology
;
prevention & control
;
surgery
;
Hemostasis, Surgical
;
adverse effects
;
methods
;
Hemostatic Techniques
;
Heparin
;
therapeutic use
;
Humans
;
Intermittent Pneumatic Compression Devices
;
Intestine, Small
;
pathology
;
Laparoscopy
;
adverse effects
;
Margins of Excision
;
Peptic Ulcer
;
etiology
;
therapy
;
Postoperative Complications
;
diagnosis
;
prevention & control
;
therapy
;
Pulmonary Embolism
;
etiology
;
therapy
;
Stents
;
Stockings, Compression
;
Thrombectomy
;
Thrombolytic Therapy
;
Venous Thrombosis
;
etiology
;
prevention & control
;
therapy